Ingalls & Snyder LLC’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,000	Closed	-$105K	–	417
2022 Q2	$105K	Buy	+15,000	New	+$105K	0.01%	398